UMB Bank’s Mural Oncology MURA Stock Holding History

UMB Bank’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$314	–	2177
2024 Q2	$314	Hold	100	–	–	﹤0.01%	2106
2024 Q1	$489	Hold	100	–	–	﹤0.01%	1986
2023 Q4	$592	Buy	+100	New	+$402	﹤0.01%	1556

Other funds holding MURA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

UMB Bank's MURA Position: Q3 2024 in Review

UMB Bank sold out of Mural Oncology (MURA) in Q3 2024, closing a stake of 100 shares — an estimated $314 sold.

UMB Bank first reported a position in MURA in Q4 2023 and held it in 3 quarters. The position peaked at $592 in Q4 2023. 74 funds tracked by Wall St. Rank hold MURA as of Q3 2024.

UMB Bank reported no remaining Mural Oncology position as of Q3 2024 after selling out during the quarter.
UMB Bank sold 100 Mural Oncology shares in Q3 2024, an estimated $314.
UMB Bank first reported a position in Mural Oncology in Q4 2023 and held it in 3 quarters.
UMB Bank's Mural Oncology position peaked at $592 in Q4 2023.
74 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2024.

Based on UMB Bank's 13F filing for Q3 2024, filed 9 Oct 2024.